| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.32 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.096 | 0.05 |